-
Signature
-
/s/ John Meloun, as Attorney-in-Fact, for Anthony Geisler
-
Issuer symbol
-
XPOF
-
Transactions as of
-
05 May 2023
-
Net transactions value
-
-$3,349
-
Form type
-
4
-
Filing time
-
09 May 2023, 18:20:14 UTC
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
XPOF |
Class A Common Stock |
Sale |
$3,349 |
-100 |
-0.03% |
$33.49 |
371,643 |
05 May 2023 |
The Anthony Geisler Trust U/A Dated 05/17/2011 |
F1, F2 |
| holding |
XPOF |
Class A Common Stock |
|
|
|
|
|
347,995 |
05 May 2023 |
Direct |
|
| holding |
XPOF |
Class B Common Stock |
|
|
|
|
|
10,702 |
05 May 2023 |
The Anthony Geisler Trust U/A Dated 05/17/2011 |
F2 |
| holding |
XPOF |
Class B Common Stock |
|
|
|
|
|
7,439,858 |
05 May 2023 |
LAG Fit, Inc. |
F3 |
| holding |
XPOF |
Class A Common Stock |
|
|
|
|
|
83,330 |
05 May 2023 |
LAG Fit, Inc. |
F3 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| holding |
XPOF |
LLC Units in Xponential Holdings LLC |
|
|
|
|
|
10,702 |
05 May 2023 |
Class A Common Stock |
10,702 |
|
The Anthony Geisler Trust U/A Dated 05/17/2011 |
F2, F4, F5, F6 |
| holding |
XPOF |
LLC Units in Xponential Holdings LLC |
|
|
|
|
|
7,439,858 |
05 May 2023 |
Class A Common Stock |
7,439,858 |
|
LAG Fit, Inc. |
F3, F4, F5, F6 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: